KATIE VO: Open Payments
NPI 1861729147 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,598 in 140 payments from 19 companies in 2025. Trend: 2023 $1,623 · 2024 $2,048 · 2025 $2,598
Food & beverage: $2,598
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 27 | $403 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 17 | $382 |
| Regeneron Healthcare Solutions, Inc. | 14 | $291 |
| PFIZER INC. | 8 | $260 |
| MAYNE PHARMA COMMERCIAL LLC | 25 | $223 |
| LEO Pharma Inc. | 9 | $180 |
| Amgen Inc. | 5 | $142 |
| Novartis Pharmaceuticals Corporation | 6 | $142 |
| Lilly USA, LLC | 6 | $137 |
| Incyte Corporation | 6 | $113 |
Products named: NEMLUVIO, ILUMYA, CIBINQO, DUPIXENT, OTEZLA, TALTZ, ADBRY, OPZELURA.
Industry payments across TX — which companies pay providers there.
